Adopting the MRD Strategy to Optimize Post-operation Adjuvant Therapies for Early Stage Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Early-stage Breast Cancer
Interventions: OTHER: The MRD strategy for high risk or MRD+ TNBC patients|OTHER: The MRD strategy for high risk or MRD+ HER2+ patients|OTHER: The MRD strategy for high risk or MRD+ ER+ patients|OTHER: The MRD strategy for low risk and MRD- TNBC patients|OTHER: The MRD strategy for low risk and MRD- HER2+ patients|OTHER: The MRD strategy for low risk and MRD- ER+ patients
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Collaborators: Beijing Huanxing Cancer Hospital|Cancer Hospital, Chinese Academy of Medical Sciences, Hebei Center